Prognostic value of the combination of seruml-kynurenine level and indoleamine 2,3-dioxygenase mRNA expression in acute myeloid leukemia

Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice

(2015) Nobuhiko Nakamura et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia

(2015) Ryoko Mabuchi et al.   LEUKEMIA & LYMPHOMA

Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics

(2014) Kenji Fukuno et al.   LEUKEMIA & LYMPHOMA

Indoleamine 2,3-dioxygenase expression and serum kynurenine concentrations in patients with diffuse large B-cell lymphoma

(2012) Soranobu Ninomiya et al.   LEUKEMIA & LYMPHOMA

Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP

(2010) Soranobu Ninomiya et al.   ANNALS OF HEMATOLOGY

The Absence of IDO Upregulates Type I IFN Production, Resulting in Suppression of Viral Replication in the Retrovirus-Infected Mouse

(2010) M. Hoshi et al.   JOURNAL OF IMMUNOLOGY

Serum concentration of L-kynurenine predicts the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP

(2009) Takeshi Yoshikawa et al.   EUROPEAN JOURNAL OF HAEMATOLOGY